S57 Male Reproductive Health Problems: From Fertilization to Senescence

Program: Symposia
Clinical/Translational Session
Sunday, April 3, 2016: 4:45 PM-6:15 PM
Room 258 (BCEC)
Chair:
Peter Y Liu, MBBS, PhD, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, CA

Nothing to Disclose: PYL
4:45 PM
Richard Michael Sharpe, PhD, MRC Centre for Reproductive Health, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom
Nothing to Disclose: RMS
5:15 PM
Niels Erik Skakkebaek, Prof, MD, DMSc, Department of Growth and Reproduction, University of Copenhagen, Faculty of Health and Medical Sciences, Rigshospitalet, Denmark, Copenhagen, Denmark
Nothing to Disclose: NES
5:45 PM
Peter J Snyder, MD, Division of Endocrinology, Diabetes and Metabolism, Perelman School of Medicine, Univ of Pennsylvania, Philadelphia, PA
Disclosures:
PJS: Ad Hoc Consultant, Watson Pharmaceuticals.
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire